We analyzed the expression profiles of different prostate tissues from several databases and found that the expression levels of ABCC5 showed an obvious progressive increase in metastatic castration-resistant prostate cancer (mCRPC) compared with benign hyperplastic tissues and primary tumor foci (Figure 1A-H, p ≤ 0.002). The gene discussed is ABCC5; the disease is neoplasm.